Jay Y Spiegel

12PUBLICATIONS
117CO-AUTHORS
Molecular targetsImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 18, 2026
RHOA Deletion Downregulates CD19 and Promotes Dysfunctional Immune Microenvironments in CAR-T Resistant Large B-cell Lymphomas.

|Feb 05, 2026
Clinical Characteristics and Outcomes of Invasive Aspergillosis in Patients with Hematological Malignancies and Transplantation and Cellular Therapies in the Contemporary Era.

Christopher M Lopez, Jose F Suarez, Maria A Mendoza

|Apr 16, 2025
Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B-cell Lymphoma.

Khushali Jhaveri, Ram Thapa, Dalia Ercan

|Aug 02, 2024
Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.

Michael D Jain, Jay Y Spiegel, Loretta J Nastoupil

|Jun 05, 2024
Incidence and outcomes of cytomegalovirus reactivation after chimeric antigen receptor T-cell therapy.

Rick Y Lin, Anthony D Anderson, Yoichiro Natori

|Dec 05, 2023
Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium.

Michael D Jain, Miriam T Jacobs, Feng Gao

Pageof 2

Frequent Collaborators

5 joint publications

David Miklos

5 joint publications

Michael D Jain

4 joint publications

Anthony D Anderson

4 joint publications

Trent Wang